Kevin Francis

442 total citations
18 papers, 327 citations indexed

About

Kevin Francis is a scholar working on Nephrology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kevin Francis has authored 18 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 5 papers in Hepatology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kevin Francis's work include Gout, Hyperuricemia, Uric Acid (5 papers), Liver Disease and Transplantation (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Kevin Francis is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (5 papers), Liver Disease and Transplantation (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Kevin Francis collaborates with scholars based in United States, France and Singapore. Kevin Francis's co-authors include Herman Sanchez, David B. Matchar, Stephen Sander, Martin Zalesak, Yu Chen, Gavin Miyasato, David Walker, Kimberly Siu, Carlos Bachier and Marcello Rotta and has published in prestigious journals such as Blood, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

Kevin Francis

17 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Francis United States 8 132 57 51 51 48 18 327
Su Been Lee United States 8 82 0.6× 53 0.9× 39 0.8× 55 1.1× 24 0.5× 24 379
V. Rosa Spain 14 148 1.1× 73 1.3× 74 1.5× 9 0.2× 245 5.1× 19 321
David Massicotte‐Azarniouch Canada 10 48 0.4× 20 0.4× 37 0.7× 28 0.5× 24 0.5× 33 221
Laurel A. Menapace United States 8 115 0.9× 88 1.5× 44 0.9× 51 1.0× 206 4.3× 16 328
Ravi Ranjan India 12 57 0.4× 222 3.9× 37 0.7× 12 0.2× 67 1.4× 37 378
Noemi Ferrante Italy 5 199 1.5× 85 1.5× 50 1.0× 28 0.5× 287 6.0× 5 378
Michael Sproule United Kingdom 10 65 0.5× 28 0.5× 63 1.2× 36 0.7× 114 2.4× 14 339
Omri Cohen Israel 10 57 0.4× 115 2.0× 69 1.4× 46 0.9× 112 2.3× 39 345
Manuel de Mora Martín Spain 9 226 1.7× 28 0.5× 61 1.2× 17 0.3× 5 0.1× 21 376
Erminia Baldacci Italy 12 51 0.4× 308 5.4× 36 0.7× 30 0.6× 46 1.0× 50 420

Countries citing papers authored by Kevin Francis

Since Specialization
Citations

This map shows the geographic impact of Kevin Francis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Francis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Francis more than expected).

Fields of papers citing papers by Kevin Francis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Francis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Francis. The network helps show where Kevin Francis may publish in the future.

Co-authorship network of co-authors of Kevin Francis

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Francis. A scholar is included among the top collaborators of Kevin Francis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Francis. Kevin Francis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Francis, Kevin, et al.. (2022). SA34 Impact of COVID-19 on Telehealth Utilization: Analysis of Komodo Healthcare Map™ Claims Data. Value in Health. 25(7). S611–S611.
3.
Butler, Merlin G., Ann M. Manzardo, Theresa V. Strong, et al.. (2020). PRO22 COST OF CARE ANALYSIS FOR U.S. PATIENTS WITH PRADER-WILLI SYNDROME (PWS). Value in Health. 23. S332–S332. 1 indexed citations
4.
McCandless, Shawn E., David Yin, Michael Yeh, et al.. (2020). SUN-604 U.S. Prevalence & Mortality of Prader-Willi Syndrome: A Population-Based Study of Medical Claims. Journal of the Endocrine Society. 4(Supplement_1). 6 indexed citations
5.
Bachier, Carlos, et al.. (2020). Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis. Transplantation and Cellular Therapy. 27(6). 504.e1–504.e6. 44 indexed citations
6.
Brigham, Mark D., Zheng Wang, Jeffrey D. Kent, et al.. (2020). Immunosuppressant Use and Gout in the Prevalent Solid Organ Transplantation Population. Progress in Transplantation. 30(2). 103–110. 5 indexed citations
7.
Yin, David, Zheng Wang, Mark D. Brigham, et al.. (2020). New-Onset Gout as an Independent Risk Factor for Returning to Dialysis After Kidney Transplantation. Transplantation Direct. 6(12). e634–e634. 4 indexed citations
8.
Brigham, Mark D., Jeffrey D. Kent, Brian LaMoreaux, et al.. (2020). A Retrospective Cohort Study of the Effect of Gout on Mortality Among Patients with a History of Kidney Transplantation. Annals of Transplantation. 25. 4 indexed citations
9.
Brigham, Mark D., Jeffrey D. Kent, Brian LaMoreaux, et al.. (2019). Prevalence of Gout in the Surviving United States Solid Organ Transplantation Population. Transplantation Proceedings. 51(10). 3449–3455. 8 indexed citations
10.
Li, Justin, Mark D. Brigham, Brian LaMoreaux, et al.. (2019). SAT0430 IMPACT OF GOUT ON ALL-CAUSE MORTALITY AMONG MEDICARE BENEFICIARIES WITH A HISTORY OF KIDNEY TRANSPLANTATION: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 78. 1304–1304. 4 indexed citations
11.
12.
Francis, Kevin, et al.. (2016). Burden of illness for super-refractory status epilepticus patients. Journal of Medical Economics. 20(1). 45–53. 22 indexed citations
13.
Francis, Kevin, Yu Chen, Stephen Sander, et al.. (2015). Healthcare utilization and costs associated with dabigatran compared to warfarin treatment in newly diagnosed patients with non-valvular atrial fibrillation. Current Medical Research and Opinion. 31(12). 2189–2195. 17 indexed citations
14.
Wade, Michael, Rohini K. Hernandez, Avanti Adhia, et al.. (2015). Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States. Clinical Epidemiology. 7. 335–335. 53 indexed citations
15.
16.
Zalesak, Martin, Kimberly Siu, Kevin Francis, et al.. (2013). Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin. Circulation Cardiovascular Quality and Outcomes. 6(5). 567–574. 119 indexed citations
17.
Zalesak, Martin, Kevin Francis, Kyle Hvidsten, et al.. (2013). Current and Future Disease Progression of the Chronic HCV Population in the United States. PLoS ONE. 8(5). e63959–e63959. 24 indexed citations
18.
Francis, Kevin, Kimberly Siu, Yu Chen, et al.. (2012). Persistence Among Patients with Non-Valvular Atrial Fibrillation Beginning Dabigatran or Warfarin. Blood. 120(21). 365–365. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Su Been Lee Breakdown of academic impact, for papers by V. Rosa Breakdown of academic impact, for papers by David Massicotte‐Azarniouch Breakdown of academic impact, for papers by Laurel A. Menapace Breakdown of academic impact, for papers by Ravi Ranjan Breakdown of academic impact, for papers by Noemi Ferrante Breakdown of academic impact, for papers by Michael Sproule Breakdown of academic impact, for papers by Omri Cohen Breakdown of academic impact, for papers by Manuel de Mora Martín Breakdown of academic impact, for papers by Erminia Baldacci
Rankless by CCL
2026